| Year |
Citation |
Score |
| 2021 |
Cillo AR, Somasundaram A, Shan F, Cardello C, Workman CJ, Kitsios GD, Ruffin A, Kunning S, Lampenfeld C, Onkar S, Grebinoski S, Deshmukh G, Methe B, Liu C, Nambulli S, ... ... Joglekar AV, et al. Critically ill COVID-19 patients exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 viral burden in the lung. Cell Reports. Medicine. 100476. PMID 34873589 DOI: 10.1016/j.xcrm.2021.100476 |
0.493 |
|
| 2021 |
Cillo AR, Somasundaram A, Shan F, Cardello C, Workman CJ, Kitsios GD, Ruffin A, Kunning S, Lampenfeld C, Onkar S, Grebinoski S, Deshmukh G, Methe B, Liu C, Nambulli S, ... ... Joglekar AV, et al. Bifurcated monocyte states are predictive of mortality in severe COVID-19. Biorxiv : the Preprint Server For Biology. PMID 33594364 DOI: 10.1101/2021.02.10.430499 |
0.488 |
|
| 2020 |
Joglekar AV, Li G. T cell antigen discovery. Nature Methods. PMID 32632239 DOI: 10.1038/S41592-020-0867-Z |
0.448 |
|
| 2019 |
Frankiw L, Mann M, Li G, Joglekar A, Baltimore D. Alternative Splicing Coupled with Transcript Degradation Modulates OAS1g Antiviral Activity. Rna (New York, N.Y.). PMID 31740586 DOI: 10.1261/Rna.073825.119 |
0.482 |
|
| 2019 |
Li G, Bethune MT, Wong S, Joglekar AV, Leonard MT, Wang JK, Kim JT, Cheng D, Peng S, Zaretsky JM, Su Y, Luo Y, Heath JR, Ribas A, Witte ON, et al. T cell antigen discovery via trogocytosis. Nature Methods. 16: 183-190. PMID 30700903 DOI: 10.1038/S41592-018-0305-7 |
0.675 |
|
| 2019 |
Joglekar AV, Leonard MT, Jeppson JD, Swift M, Li G, Wong S, Peng S, Zaretsky JM, Heath JR, Ribas A, Bethune MT, Baltimore D. T cell antigen discovery via signaling and antigen-presenting bifunctional receptors. Nature Methods. 16: 191-198. PMID 30700902 DOI: 10.1038/S41592-018-0304-8 |
0.548 |
|
| 2019 |
Joglekar A, Leonard M, Jeppson J, Swift M, Baltimore D. T cell antigen discovery using signaling and antigen presenting bifunctional receptors (SABRs) Protocol Exchange. DOI: 10.1038/Protex.2018.126 |
0.375 |
|
| 2018 |
Kuo CY, Long JD, Campo-Fernandez B, de Oliveira S, Cooper AR, Romero Z, Hoban MD, Joglekar AV, Lill GR, Kaufman ML, Fitz-Gibbon S, Wang X, Hollis RP, Kohn DB. Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome. Cell Reports. 23: 2606-2616. PMID 29847792 DOI: 10.1016/J.Celrep.2018.04.103 |
0.698 |
|
| 2018 |
Joglekar AV, Liu Z, Weber JK, Ouyang Y, Jeppson JD, Noh WJ, Lamothe-Molina PA, Chen H, Kang SG, Bethune MT, Zhou R, Walker BD, Baltimore D. T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable. Proceedings of the National Academy of Sciences of the United States of America. PMID 29437954 DOI: 10.1073/Pnas.1718659115 |
0.509 |
|
| 2017 |
Joglekar AV, Sandoval S. Pseudotyped Lentiviral Vectors: One Vector, Many Guises. Human Gene Therapy Methods. PMID 28870117 DOI: 10.1089/Hgtb.2017.084 |
0.385 |
|
| 2017 |
Bethune MT, Joglekar AV. Personalized T cell-mediated cancer immunotherapy: progress and challenges. Current Opinion in Biotechnology. 48: 142-152. PMID 28494274 DOI: 10.1016/J.Copbio.2017.03.024 |
0.444 |
|
| 2015 |
Hoban MD, Cost GJ, Mendel MC, Romero Z, Kaufman ML, Joglekar AV, Ho M, Lumaquin D, Gray D, Lill GR, Cooper AR, Urbinati F, Senadheera S, Zhu A, Liu PQ, et al. Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells. Blood. 125: 2597-604. PMID 25733580 DOI: 10.1182/Blood-2014-12-615948 |
0.693 |
|
| 2015 |
Kuo CY, Hoban MD, Joglekar AV, Young CS, Kleinman J, Abele AN, Kohn DB. 121. Targeted Gene Therapy in the Treatment of X-Linked Hyper IgM Syndrome Molecular Therapy. 23: S50. DOI: 10.1016/S1525-0016(16)33726-1 |
0.622 |
|
| 2015 |
Hoban MD, Mendel MC, Romero Z, Kaufman ML, Joglekar AV, Ho M, Lumaquin D, Gray D, Lill GR, Cooper AR, Urbinati F, Senadheera S, Zhu A, Liu P, Paschon DE, et al. 115. Correction of the Sickle-Cell Disease Mutation in Human Hematopoietic Stem/Progenitor Cells Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)33720-0 |
0.645 |
|
| 2015 |
Kuo CY, Hoban MD, Joglekar AV, Kohn DB. Site Specific Gene Correction of Defects in CD40 Ligand Using the Crispr/Cas9 Genome Editing Platform Journal of Allergy and Clinical Immunology. 135: AB17. DOI: 10.1016/J.Jaci.2014.12.987 |
0.607 |
|
| 2014 |
Joglekar AV, Stein L, Ho M, Hoban MD, Hollis RP, Kohn DB. Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectors. Human Gene Therapy. 25: 599-608. PMID 24568341 DOI: 10.1089/Hum.2013.211 |
0.562 |
|
| 2014 |
Kuo CY, Joglekar A, Kohn DB. Patient Specific Targeted Gene Therapy In The Treatment Of X-Linked Hyper-IgM Syndrome Journal of Allergy and Clinical Immunology. 133: AB162. DOI: 10.1016/J.Jaci.2013.12.588 |
0.505 |
|
| 2013 |
Joglekar AV, Hollis RP, Kuftinec G, Senadheera S, Chan R, Kohn DB. Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1705-17. PMID 23857176 DOI: 10.1038/Mt.2013.106 |
0.53 |
|
| 2013 |
Hoban MD, Joglekar AV, Gray D, Kaufman ML, Urbinati F, Senadheera S, Cost G, Reik A, Holmes MC, Gregory PD, Hollis RP, Kohn DB. Zinc Finger Nucleases Targeting The β-Globin Locus Drive Efficient Correction Of The Sickle Mutation In CD34+ Cells Blood. 122: 2904-2904. DOI: 10.1182/Blood.V122.21.2904.2904 |
0.634 |
|
| 2009 |
Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY, Bapat SA. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells (Dayton, Ohio). 27: 2059-68. PMID 19544473 DOI: 10.1002/Stem.154 |
0.424 |
|
| Show low-probability matches. |